CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $2.07M invested in Chemomab Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
1
Two Sigma Securities
New York
|
$20.4K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$8.94K |
| 3 |
3
Two Sigma Advisers
New York
|
$29.4K |
| 4 |
4
JPMorgan Chase & Co
New York
|
$1 |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$2.18K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
XT
3
XTX Topco
George Town,
Cayman Islands
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
Two Sigma Investments
New York
|
$31.2K |
